Professor Shane Grey
Professor Shane Grey received his PhD immunology training at Monash University and his post-doctoral training as a transplant immunologist at Harvard Medical School, USA. Shane later became involved in islet transplantation and type I diabetes research though the JDRF Islet Transplant Center at Harvard in the late 1990’s. In 2000 he received a JDRF Career Development Award to establish a research program aiming to understand how islet beta cells die; and in 2001 was appointed as Assistant Professor in Surgery at Harvard Medical School. In 2003 Shane received a NSW BioFirst Award and was recruited back to Australia to the Garvan Institute of Medical Research. In 2007, Shane was awarded as a Key Opinion Leader (KOL) in transplantation by The Transplantation Society International. In 2010 Shane received a JDRF- Macquarie Group Foundation Innovation Award for his work in T1D. Shane is the head of a transplant immunology research team at Garvan; a lead investigator on Australia's first clinical islet transplant program at Westmead; Program Director of a national NHMRC/JDRF research program for T1D and a founder of the Australian Islet Study Group.
- 2000JDRF Career Development Award
- 2001Assistant Professor in Surgery - Harvard Medical School.
- 2003NSW-BioFirst Award
- 2003Senior Research Fellow - Garvan Medical Research Institute - Sydney - Australia.
- 2005Mary Jane Kugel Award - JDRF New York
- 2007“Key Opinion Leader (KOL)” award in transplantation – The international Transplantation Society (TTS)
- 2008Mary Jane Kugel Award - JDRF New York
- 2009ARC Future Fellowship
- 2009Australian Research Council (ARC) Future Fellow Award
- 2010JDRF and Macquarie Group Foundation Diabetes Research Innovation Award
- 2011Associate Professor - Faculty of Medicine - UNSW - Sydney - Australia
- 2012TSANZ “Ian McKenzie Prize” – for outstanding contributions in Transplantation
- 2013NHMRC Senior Research Fellowship SRF-A (6th Year Extension 2015)
- 2018NHMRC Senior Research Fellowship (SRF-B)
- 2022Transplant international : official journal of the European Society for Organ Transplantation10.3389/ti.2022.10817
Genetic Engineering of Immune Evasive Stem Cell-Derived Islets.
The retroelement Lx9 puts a brake on the immune response to virus infection.
Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity.
- 2012Cell transplantation10.3727/096368912X647180
Hypoxia-inducible factor-1α (HIF-1α) potentiates β-cell survival after islet transplantation of human and mouse islets.
- 2006Nature immunology10.1038/ni1310
Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1.